Multiplexed nanomedicine for brain tumors: nanosized Hercules to tame our Lernaean Hydra inside?

Nanomedicine (Lond)

Department of Neurological Surgery, Brain Tumor Research Institute, The Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.

Published: October 2017

Download full-text PDF

Source
http://dx.doi.org/10.2217/nnm-2017-0260DOI Listing

Publication Analysis

Top Keywords

multiplexed nanomedicine
4
nanomedicine brain
4
brain tumors
4
tumors nanosized
4
nanosized hercules
4
hercules tame
4
tame lernaean
4
lernaean hydra
4
hydra inside?
4
multiplexed
1

Similar Publications

Demystifying EV heterogeneity: emerging microfluidic technologies for isolation and multiplexed profiling of extracellular vesicles.

Lab Chip

January 2025

The MOE Key Laboratory of Spectrochemical Analysis & Instrumentation, The Key Laboratory of Chemical Biology of Fujian Province, State Key Laboratory of Physical Chemistry of Solid Surfaces, Department of Chemical Biology, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China.

Extracellular vesicles (EVs) are heterogeneous lipid containers carrying complex molecular cargoes, including proteins, nucleic acids, glycans, These vesicles are closely associated with specific physiological characteristics, which makes them invaluable in the detection and monitoring of various diseases. However, traditional isolation methods are often labour-intensive, inefficient, and time-consuming. In addition, single biomarker analyses are no longer accurate enough to meet diagnostic needs.

View Article and Find Full Text PDF

Implantable systems with chronic stability, high sensing performance, and extensive spatial-temporal resolution are a growing focus for monitoring and treating several diseases such as epilepsy, Parkinson's disease, chronic pain, and cardiac arrhythmias. These systems demand exceptional bendability, scalable size, durable electrode materials, and well-encapsulated metal interconnects. However, existing chronic implantable bioelectronic systems largely rely on materials prone to corrosion in biofluids, such as silicon nanomembranes or metals.

View Article and Find Full Text PDF

The Long-Term Impact of Polysaccharide-Coated Iron Oxide Nanoparticles on Inflammatory-Stressed Mice.

J Xenobiot

November 2024

Experimental Radiology, Institute of Diagnostic and Interventional Radiology, Jena University Hospital, Friedrich Schiller University Jena, Am Klinikum 1, D-07747 Jena, Germany.

Since iron oxide nanoparticles (IONPs) are expected to be important tools in medical care, patients with inflammatory diseases will be increasingly exposed to IONPs in the future. Here, we assessed the short- and long-term impact of polysaccharide (PS)-coated IONPs on mice with persistent systemic inflammation. To this end, PS-IONPs were synthetized by a core-shell method.

View Article and Find Full Text PDF

Research Advances of Cellular Nanoparticles as Multiplex Countermeasures.

ACS Nano

November 2024

Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, Shu and K.C. Chien and Peter Farrell Collaboratory, University of California San Diego, La Jolla, California 92093, United States.

Article Synopsis
  • Cellular nanoparticles (CNPs) are created by coating natural cell membranes over nanoparticle cores to mimic cellular functions for therapeutic uses, especially in neutralizing harmful molecules and pathogens.
  • The review categorizes advancements in CNP technology into four areas: neutralization through cell binding, combined mechanisms using both cell membranes and nanoparticle cores, continuous neutralization via enzymes, and enhanced strategies with modified membranes.
  • By exploring the relationship between structure and function in CNP designs, the article aims to inspire better nanoformulations and innovative applications to tackle unresolved medical challenges.
View Article and Find Full Text PDF

, Fusion-Free, Multiplexed Detection of Small Extracellular Vesicle miRNAs for Cancer Diagnostics.

Anal Chem

October 2024

Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

Tumor-derived small extracellular vesicle (sEV) microRNAs (miRNAs) are emerging biomarkers for cancer diagnostics. Conventional sEV miRNA detection methods necessitate the lysis of sEVs, rendering them laborious and time-consuming and potentially leading to damage or loss of miRNAs. Membrane fusion-based detection of sEV miRNAs involves the preparation of probe-loaded vesicles (, liposomes or cellular vesicles), which are typically sophisticated and require specialist equipment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!